Speaker Details

Amit Garg, MD, FAAD

Amit Garg, MD, FAAD

Northwell Health

BIOGRAPHY

Dr. Garg is Professor and Founding Chairman for the Department of Dermatology at the Zucker School of Medicine at Hofstra Northwell. He is also Professor in the Center for Health Innovation and Outcomes Research at the Feinstein Institutes for Medical Research. He is immediate past president for the Northwell Health Physician Partners, a medical group representing over 6000 doctors at Northwell Health in New York. Dr. Garg’s subspecialty expertise is interdisciplinary based in caring for patients with autoimmune and inflammatory conditions including hidradenitis suppurativa and psoriasis. Dr. Garg's funded research interests include identification of comorbidities using ‘Big Data’, and development of a core outcome set for clinical trials for dermatologic diseases. Dr. Garg is Chair of the Council on Education for the American Academy of Dermatology. He has held leadership roles within national professional organizations, including C3, HiSTORIC, the Hidradenitis Suppurativa Foundation, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, and the National Psoriasis Foundation. Dr. Garg past Vice Chair for the Dermatology's Residency Review Committee of the Accreditation Counsel of Graduate Medical Education (ACGME). Dr. Garg serves on the editorial board for the Journal of the American Academy of Dermatology and he is the Outcomes section editor for the journal Dermatology. He has over 200 publications in the peer reviewed literature, the majority of which are original research articles. Dr. Garg was awarded the 2016 Thomas G. Pearson, EdD Memorial Education Award by the American Academy of Dermatology.

SESSIONS

P001 Advances in Clinical Research: Highlights from the Innovation Academy’s Scientific Abstracts
Jul 17, 2026 10:00 AM - 12:00 AM Mercury Ballroom
P004 A New Paradigm in the Management of the Hidradenitis Suppurativa Disease Spectrum
Jul 17, 2026 1:00 PM - 12:00 AM Trianon Ballroom
P007 Hidradenitis Suppurativa: Case-Based Clinical Pearls
Jul 18, 2026 8:45 AM - 12:00 AM Sutton North
PRL07 Phenotyping Hidradenitis Suppurativa (HS): Findings of a Collaborative Artificial Intelligence (AI) Initiative
Jul 18, 2026 1:00 PM - 12:00 AM Trianon Ballroom

DISCLOSURES

AbbVie – Advisory Board(Honoraria); Almirall – Consultant (1099 relationship)(Fees); Bluefin Biomedicine – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria); Insmed Incorporated – Consultant (1099 relationship)(Honoraria); Leo Pharma – Advisory Board(Honoraria); Navigator Medicines – Consultant (1099 relationship)(Fees); Novartis – Consultant(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Otsuka Pharmaceutical Co., Ltd. – Consultant (1099 relationship)(Fees); Priovant Therapeutics – Consultant (1099 relationship)(Fees); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Fees); UCB – Consultant(Honoraria); Zura Bio – Consultant (1099 relationship)(Fees);